[1] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|
[2] |
BIAN Xiaojie, YE Dingwei.
New ideas of androgen deprivation therapy for prostate cancer: new progress in clinical research of testosterone maximum control
[J]. China Oncology, 2021, 31(12): 1209-1214.
|
[3] |
WANG Zhihen , MAO Peimin , JIANG Hongyuan , FAN Lingling .
Assessment of the diagnostic value of CPH-I, CA12-5 and HE4 for cancer prediction in women with ovarian masses with papillary projections diagnosed by ultrasound
[J]. China Oncology, 2020, 30(8): 599-604.
|
[4] |
WANG Xiaoqin, FU Xinlei, MA Ruyue, YANG Lina, CHEN Yaping, ZHANG Liwen.
Sema3A regulates metastasis through epithelial-mesenchymal transition/matrix metalloproteinase-2 in epithelial ovarian cancer
[J]. China Oncology, 2020, 30(6): 428-434.
|
[5] |
LI Peng, MA Xiaoying, LI Xiaojia, JIN Wenqi, DING Xufeng, GUO Xiutian.
Establishment and verification of a stratification model of colon cancer stem cell epithelial-mesenchymal transition
[J]. China Oncology, 2019, 29(2): 100-110.
|
[6] |
LI Yihao, DAI Qian, WANG Beili, PAN Baishen, GUO Wei.
Correlation between cancer cell stemness and glucose metabolism characteristics in hepatocellular carcinoma
[J]. China Oncology, 2019, 29(10): 773-779.
|
[7] |
ZHANG Sa, XU Jiahui, LIU Suling, et al.
Chromatin remodeling protein MORC2 promotes a breast cancer stem-like phenotype by regulating ALDH1A3 expression
[J]. China Oncology, 2017, 27(3): 161-168.
|
[8] |
WANG Jun, SU Xiaosan, YANG Liu, et al.
Bone marrow mesenchymal stem cells prevent pulmonary tumor metastasis after surgery in a mouse model
[J]. China Oncology, 2017, 27(2): 89-94.
|
[9] |
ZHAO Ning, FU shen.
Recent advances in breast cancer stem cell phenotypes and clinical application
[J]. China Oncology, 2016, 26(8): 699-703.
|
[10] |
ZHANG Pengnan, SUN Hong, JIANG Hongyuan.
Expression of miR-483-5p in epithelial ovarian cancer and its effects on cisplatin resistance in epithelial ovarian cancer cells
[J]. China Oncology, 2016, 26(5): 394-398.
|
[11] |
WANG Qifeng, XU Qinghua, CHEN Jinying, et al.
Identification and validation of a novel gene expression signature for diagnosing tumor tissue origin
[J]. China Oncology, 2016, 26(10): 801-812.
|
[12] |
JIANG Ling, CAO Xiaozheng, LI Cheng, et al.
The effects of casticin on phosphorylation of FoxO3a in stem-like cells derived from ovarian cancer SKOV3 cell line
[J]. China Oncology, 2015, 25(5): 360-364.
|
[13] |
WANG Jinghao, REN Yuan, ZHANG Rong, et al.
Effects of CXXC finger protein 5 up-regulated expression in epithelial ovarian cancer
[J]. China Oncology, 2015, 25(4): 260-268.
|
[14] |
LIU Hong, WANG Yujing, BIAN Lei, et al.
Study on the chemoresistance of CD44+/CD24+ Siha cells to cisplatin and its mechanisms
[J]. China Oncology, 2015, 25(10): 785-790.
|
[15] |
MA Li-yuan, HAO Si-guo.
Clinical research progresses in umbilical cord blood transplantation in the treatment of hematologic malignancies
[J]. China Oncology, 2014, 24(10): 732-737.
|